Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19
Authors
Keywords
-
Journal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 329, Issue 14, Pages 1183
Publisher
American Medical Association (AMA)
Online
2023-04-11
DOI
10.1001/jama.2023.4480
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How to Use and Interpret the Results of a Platform Trial
- (2022) Jay J. H. Park et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- What Are Adaptive Platform Clinical Trials and What Role May They Have in Cardiovascular Medicine?
- (2022) Patrick R. Lawler et al. CIRCULATION
- Tidal Volume–Dependent Activation of the Renin-Angiotensin System in Experimental Ventilator-Induced Lung Injury
- (2022) Xinjun Mao et al. CRITICAL CARE MEDICINE
- Impact of renin–angiotensin–aldosterone system inhibitors on COVID-19
- (2022) Yasushi Matsuzawa et al. HYPERTENSION RESEARCH
- Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19
- (2022) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Renin-Angiotensin System as a Component of Biotrauma in Acute Respiratory Distress Syndrome
- (2022) Katharina Krenn et al. Frontiers in Physiology
- Efficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury
- (2022) Michael A. Puskarich et al. JAMA Network Open
- Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019
- (2022) Rafael L. Camargo et al. Frontiers in Cardiovascular Medicine
- The Renin-Angiotensin System in Acute Lung Injury*
- (2022) Patrick R. Lawler et al. CRITICAL CARE MEDICINE
- Therapeutic advances in COVID-19
- (2022) Naoka Murakami et al. Nature Reviews Nephrology
- Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension
- (2022) Sonali R. Gnanenthiran et al. Journal of the American Heart Association
- Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
- (2022) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial
- (2022) Meg J Jardine et al. BMJ-British Medical Journal
- Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19
- (2021) Renato D. Lopes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
- (2021) Jordana B Cohen et al. Lancet Respiratory Medicine
- Angiotensin-Converting Enzyme 2 (ACE2) Elevation in Severe COVID-19
- (2021) Roman Reindl-Schwaighofer et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
- (2021) Susanne Rysz et al. Nature Communications
- Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19
- (2021) Ranu Baral et al. JAMA Network Open
- Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
- (2021) Yaseen M. Arabi et al. INTENSIVE CARE MEDICINE
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
- (2021) Axel Bauer et al. Lancet Respiratory Medicine
- Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome
- (2021) Mareike Gierhardt et al. European Respiratory Review
- Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- Understanding the Renin-Angiotensin-Aldosterone-SARS-CoV-Axis: A Comprehensive Review
- (2020) Nicholas E. Ingraham et al. EUROPEAN RESPIRATORY JOURNAL
- Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system?
- (2020) François Silhol et al. HYPERTENSION RESEARCH
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom
- (2020) Sheng-Chia Chung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- ACE2, Much More Than Just a Receptor for SARS-COV-2
- (2020) Lobelia Samavati et al. Frontiers in Cellular and Infection Microbiology
- Quasi-Oracle Estimation of Heterogeneous Treatment Effects
- (2020) X Nie et al. BIOMETRIKA
- Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
- (2020) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Antihypertensive Medications on Sepsis-Related Outcomes
- (2019) Joohae Kim et al. CRITICAL CARE MEDICINE
- Effect of Renin-Angiotensin-Aldosterone System Inhibitors on Short-Term Mortality After Sepsis
- (2019) Wan-Ting Hsu et al. HYPERTENSION
- Bayesian Hierarchical Models
- (2018) Anna E. McGlothlin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiotensin-Converting Enzyme Inhibition Attenuates Lipopolysaccharide-Induced Lung Injury by Regulating the Balance Between Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 and Inhibiting Mitogen-Activated Protein Kinase Activation
- (2015) Yingchuan Li et al. SHOCK
- Genomic responses in mouse models poorly mimic human inflammatory diseases
- (2013) Junhee Seok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Population-Based Study of Statins, Angiotensin II Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors on Pneumonia-Related Outcomes
- (2012) E. M. Mortensen et al. CLINICAL INFECTIOUS DISEASES
- Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
- (2012) D. Caldeira et al. BMJ-British Medical Journal
- Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for Physicians
- (2011) William H. Shrank et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist
- (2011) Roelie M Wösten-van Asperen et al. JOURNAL OF PATHOLOGY
- Ventilator-Induced Inflammatory Response in Lipopolysaccharide-Exposed Rat Lung Is Mediated by Angiotensin-Converting Enzyme
- (2010) Roelie M. Wösten-van Asperen et al. AMERICAN JOURNAL OF PATHOLOGY
- Recombinant angiotensin-converting enzyme 2 improves pulmonary blood flow and oxygenation in lipopolysaccharide-induced lung injury in piglets
- (2010) Benedikt Treml et al. CRITICAL CARE MEDICINE
- Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models*
- (2009) Satoshi Hagiwara et al. CRITICAL CARE MEDICINE
- Angiotensin II type-1 receptor antagonist attenuates LPS-induced acute lung injury
- (2009) Fei Wang et al. CYTOKINE
- Modulation of the renin–angiotensin–aldosterone system in sepsis: a new therapeutic approach?
- (2009) Diamantino Ribeiro Salgado et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- LOSARTAN PREVENTS SEPSIS-INDUCED ACUTE LUNG INJURY AND DECREASES ACTIVATION OF NUCLEAR FACTORκB AND MITOGEN-ACTIVATED PROTEIN KINASES
- (2009) Lihan Shen et al. SHOCK
- Captopril decreases plasminogen activator inhibitor-1 in rats with ventilator-induced lung injury
- (2008) Chung-Ming Chen et al. CRITICAL CARE MEDICINE
- ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin
- (2007) R. M. Wosten-van Asperen et al. EUROPEAN RESPIRATORY JOURNAL
- Losartan Attenuates Ventilator-Induced Lung Injury
- (2007) Shanglong Yao et al. JOURNAL OF SURGICAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started